240 related articles for article (PubMed ID: 33003084)
21. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
[TBL] [Abstract][Full Text] [Related]
22. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
[TBL] [Abstract][Full Text] [Related]
23. Nutritional interventions in patients with graft-versus-host disease.
Seguy D; Hueso T
Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):455-462. PubMed ID: 37389472
[TBL] [Abstract][Full Text] [Related]
24. Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans.
Norona J; Apostolova P; Schmidt D; Ihlemann R; Reischmann N; Taylor G; Köhler N; de Heer J; Heeg S; Andrieux G; Siranosian BA; Schmitt-Graeff A; Pfeifer D; Catalano A; Frew IJ; Proietti M; Grimbacher B; Bulashevska A; Bhatt AS; Brummer T; Clauditz T; Zabelina T; Kroeger N; Blazar BR; Boerries M; Ayuk F; Zeiser R
Blood; 2020 Sep; 136(12):1442-1455. PubMed ID: 32542357
[TBL] [Abstract][Full Text] [Related]
25. Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
Rondon-Clavo C; Scordo M; Hilden P; Shah GL; Cho C; Maloy MA; Papadopoulos EB; Jakubowski AA; O'Reilly RJ; Gyurkocza B; Castro-Malaspina H; Tamari R; Shaffer BC; Perales MA; Jaimes EA; Giralt SA
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2517-2522. PubMed ID: 30055353
[TBL] [Abstract][Full Text] [Related]
26. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
27. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study.
Bilinski J; Robak K; Peric Z; Marchel H; Karakulska-Prystupiuk E; Halaburda K; Rusicka P; Swoboda-Kopec E; Wroblewska M; Wiktor-Jedrzejczak W; Basak GW
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1087-1093. PubMed ID: 26900084
[TBL] [Abstract][Full Text] [Related]
28. Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice.
Buchele V; Büttner-Herold M; Vogler T; Neurath MF; Hildner K
J Vis Exp; 2019 Feb; (144):. PubMed ID: 30799849
[TBL] [Abstract][Full Text] [Related]
29. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
[TBL] [Abstract][Full Text] [Related]
30. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
[TBL] [Abstract][Full Text] [Related]
31. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
32. Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
Gao Y; Shan W; Gu T; Zhang J; Wu Y; Li X; Zeng X; Zhou H; Chen Z; Xiao H
Front Immunol; 2021; 12():785774. PubMed ID: 34987512
[TBL] [Abstract][Full Text] [Related]
33. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
[TBL] [Abstract][Full Text] [Related]
34. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
[TBL] [Abstract][Full Text] [Related]
35. Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation.
Pasic I; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Mattsson J; Michelis FV
Ann Hematol; 2020 Jun; 99(6):1377-1387. PubMed ID: 32382774
[TBL] [Abstract][Full Text] [Related]
36. Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.
Iyengar S; Zhan C; Lu J; Korngold R; Schwartz DH
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1104-11. PubMed ID: 24796280
[TBL] [Abstract][Full Text] [Related]
37. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.
Burgos da Silva M; Ponce DM; Dai A; M Devlin S; Gomes ALC; Moore G; Slingerland J; Shouval R; Armijo GK; DeWolf S; Fei T; Clurman A; Fontana E; Amoretti LA; Wright RJ; Andrlova H; Miltiadous O; Perales MA; Taur Y; Peled JU; van den Brink MRM
Blood; 2022 Dec; 140(22):2385-2397. PubMed ID: 35969834
[TBL] [Abstract][Full Text] [Related]
38. Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation.
Gjærde LK; Ostrowski SR; Jørgensen NR; Schierbeck F; Andersen NS; Friis LS; Kornblit B; Petersen SL; Schjødt I; Sengeløv H
Transpl Immunol; 2022 Oct; 74():101650. PubMed ID: 35718288
[TBL] [Abstract][Full Text] [Related]
39. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
40. Increased Infections and Delayed CD4
Khimani F; Ranspach P; Elmariah H; Kim J; Whiting J; Nishihori T; Locke FL; Perez Perez A; Dean E; Mishra A; Perez L; Lazaryan A; Jain MD; Nieder M; Liu H; Faramand R; Hansen D; Alsina M; Ochoa L; Davila M; Anasetti C; Pidala J; Bejanyan N
Transplant Cell Ther; 2021 Nov; 27(11):940-948. PubMed ID: 34329754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]